Experience of Ceftazidime/avibactam in a UK tertiary cardiopulmonary specialist center.
Lisa NwankwoZahraa ButtSilke SchelenzPublished in: Expert review of anti-infective therapy (2020)
Our study showed that Antimicrobial stewardship interventions led to a more appropriate use of Ceftazidime/avibactam (as measured by duration of therapy), preserving it as a treatment option for MDR infections.